TCL Archive Pooled Analysis of 12 Seperate Yervoy Studies Shows Survival-Curve Plateau at 3 Years October 25, 2013
TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004